Showing results (151-160 of 339) with videos related to

Sort By:
Pageof 34
Ejhaem|January 27, 2025
HLA-matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AMLTakaya Mitsuyoshi, Yasuyuki Arai, Tadakazu Kondo, et al.
International Journal of Hematology|May 25, 2024
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trialTakanori Teshima, Yasushi Onishi, Koji Kato, et al.
Transplantation and Cellular Therapy|June 6, 2026
Adjusting Disease Risk Index for Regional Variations and Donor SelectionMakoto Iwasaki, Yachiyo Kuwatsuka, Hiromi Hayashi, et al.
Blood Advances|February 2, 2022
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donorsMasaharu Tamaki, Kazuaki Kameda, Shun-Ichi Kimura, et al.
Blood Advances|January 14, 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCTShunto Kawamura, Daishi Nakagawa, Takashi Nagayama, et al.
International Journal of Hematology|March 21, 2025
Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantationTakeshi Hagino, Kazuhiro Ikegame, Hidenori Tanaka, et al.
International Journal of Hematology|November 14, 2024
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host diseaseKotaro Miyao, Makoto Murata, Tetsuya Nishida, et al.
Transplantation and Cellular Therapy|December 18, 2023
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic SyndromeYosuke Nakaya, Hideo Koh, Takaaki Konuma, et al.
Hematological Oncology|April 8, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantationYutaka Shimazu, Makoto Murata, Takeshi Kondo, et al.
Cytotherapy|March 11, 2024
Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemiaSho Shibata, Yasuyuki Arai, Tadakazu Kondo, et al.
Pageof 34